KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $6.23 $7.87 Friday, 26th Apr 2024 ARDX stock ended at $6.42. This is 1.74% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 4.52% from a day low at $6.31 to a day high of $6.59.
90 days $6.23 $10.13
52 weeks $3.16 $10.13

Historical Ardelyx prices

Date Open High Low Close Volume
Mar 07, 2016 $9.54 $9.54 $9.54 $9.54 145 600
Mar 04, 2016 $9.14 $9.14 $9.14 $9.14 207 400
Mar 03, 2016 $10.06 $10.06 $10.06 $10.06 143 400
Mar 02, 2016 $10.54 $10.54 $10.54 $10.54 203 900
Mar 01, 2016 $10.25 $10.25 $10.25 $10.25 208 900
Feb 29, 2016 $9.66 $9.66 $9.66 $9.66 273 800
Feb 26, 2016 $9.94 $9.94 $9.94 $9.94 120 500
Feb 25, 2016 $9.84 $9.84 $9.84 $9.84 122 500
Feb 24, 2016 $10.09 $10.09 $10.09 $10.09 137 400
Feb 23, 2016 $10.04 $10.04 $10.04 $10.04 225 400
Feb 22, 2016 $10.89 $10.89 $10.89 $10.89 102 900
Feb 19, 2016 $10.85 $10.85 $10.85 $10.85 159 000
Feb 18, 2016 $10.45 $10.45 $10.45 $10.45 133 900
Feb 17, 2016 $11.26 $11.26 $11.26 $11.26 194 000
Feb 16, 2016 $10.59 $10.59 $10.59 $10.59 116 500
Feb 12, 2016 $10.22 $10.22 $10.22 $10.22 139 800
Feb 11, 2016 $9.38 $9.38 $9.38 $9.38 176 500
Feb 10, 2016 $9.40 $9.40 $9.40 $9.40 150 000
Feb 09, 2016 $9.16 $9.16 $9.16 $9.16 173 800
Feb 08, 2016 $9.10 $9.10 $9.10 $9.10 288 400
Feb 05, 2016 $9.82 $9.82 $9.82 $9.82 210 000
Feb 04, 2016 $10.10 $10.10 $10.10 $10.10 135 900
Feb 03, 2016 $9.87 $9.87 $9.87 $9.87 344 100
Feb 02, 2016 $9.87 $9.87 $9.87 $9.87 144 900
Feb 01, 2016 $10.57 $10.57 $10.57 $10.57 159 800
Click to get the best stock tips daily for free!

About Ardelyx

Ardelyx Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel syndrome with constipation, as well as in Phase III clinical trial to control serum phosphorus in adult pat... ARDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT